NasdaqGM - Nasdaq Real Time Price USD
ArriVent BioPharma, Inc. (AVBP)
21.17
+0.09
+(0.43%)
At close: 4:00:01 PM EDT
21.17
0.00
(0.00%)
After hours: 4:20:00 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| GORDON CARL L Director and Beneficial Owner of more than 10% of a Class of Security | Purchase | Jan 30, 2024 | -- |
| HEALY JAMES I Director | Purchase | Jan 30, 2024 | -- |
| HILLHOUSE INVESTMENT MANAGEMENT, LTD. Beneficial Owner of more than 10% of a Class of Security | Purchase | Jan 30, 2024 | -- |
| LACHAPELLE ROBIN Chief Operating Officer | Conversion of Exercise of derivative security | Sep 19, 2024 | 519,060 |
| ORBIMED ADVISORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Purchase | Jan 30, 2024 | -- |
Related Tickers
BCAX Bicara Therapeutics Inc.
15.63
+0.77%
ARTV Artiva Biotherapeutics, Inc.
2.4500
0.00%
CTNM Contineum Therapeutics, Inc.
4.5200
-4.64%
MAZE Maze Therapeutics, Inc.
7.70
-19.37%
MBX MBX Biosciences, Inc.
9.27
+3.11%
CGON CG Oncology, Inc.
21.52
+3.81%
603233.SS DaShenLin Pharmaceutical Group Co., Ltd.
17.46
+0.34%
1OT.F Ovid Therapeutics Inc.
0.2260
+15.31%
UCB.VI UCB SA
145.60
-0.31%
RFM.F Sensorion SA
0.1210
-13.57%